PF-Atlas › Clinical Trials › NCT03969888

A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222

ABBV-3067 · Phase 2

Registry ID

NCT03969888

Phase

Phase 2

Status

Completed

Drug / intervention

ABBV-3067

Sponsor

AbbVie

Start

2019-12-11

About this trial

ABBV-3067 is evaluated in NCT03969888, a Phase 2 idiopathic pulmonary fibrosis study sponsored by AbbVie. Current status: Completed.

View NCT03969888 on ClinicalTrials.gov →

Explore related

All ABBV-3067 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT03969888 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.